Claim OwnershipHealth Newsfeed – Johns Hopkins Medicine Podcasts
Subscribed: 180Played: 5,644
Subscribe
© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.
Description
1681 Episodes
Reverse
Brain organoids, collections of cells found in the brain, have been grown from blood samples of people with Alzheimer’s disease and used to assess the impact of a drug called escitalopram in a new study. Vasiliki Machairaki, study leader and … A model of your brain may one day be grown in a lab, Elizabeth Tracey reports Read More »
Extracellular vesicles are membrane bound packages cells use to jettison materials from inside the cell, a sort of trash can. Johns Hopkins genetic medicine expert Vasiliki Machairaki has shown in a new study that these vesicles may be a means … What can be learned from what cells dispose of? Elizabeth Tracey reports Read More »
What might a model of the hindbrain, which helps control functions like sleep, breathing and heart rate, tell us about using a common depression drug in people with Alzheimer’s disease? Genetic medicine expert Vasiliki Machairaki at Johns Hopkins says her … Brain organoids can resemble specific parts of the brain, Elizabeth Tracey reports Read More »
Drugs to manage symptoms of Alzheimer’s disease may work in some people but not in others. Now a new method using brain organoids, which are derived from a person’s own blood sample, may help determine whether a specific medication is … Can drugs to manage Alzheimer’s disease be tested in organoids? Elizabeth Tracey reports Read More »
Brain organoids are lab grown clusters of cells that have several of the cell types found in someone’s brain. Cells taken from a person’s blood are coaxed to become stem cells, then differentiate into brain cells. Vasiliki Machairaki, a genetic … Can brain organoids help in treating people with Alzheimer’s disease? Elizabeth Tracey reports Read More »
Medicaid reductions being rolled out this year are poised to dramatically reduce cancer screening for millions, a new study estimates. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, takes a look at the numbers. Nelson: This is … Medicaid reductions may impact screening for cancer, Elizabeth Tracey reports Read More »
Breast cancer screening is associated with false positives, where women are referred for further assessments and procedures that may be unnecessary. Does it help to stratify women based on risk factors like genetics before they have screening? Johns Hopkins Kimmel … Should breast cancer screening be targeted to those at greatest risk? Elizabeth Tracey reports Read More »
People who were older and had advanced cancers benefited from a telephone-based intervention designed to regularly assess their symptoms and refer them to expert clinicians, by reducing their visits to emergency departments and need for hospitalization. Kimmel Cancer Center director … Can older people with cancer benefit from telephone based contact? Elizabeth Tracey reports Read More »
Seventy percent of people diagnosed with cancer in the United States will still be alive five years later, the American Cancer Society reports. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, says yes, and. Nelson: There's still … Good news on cancer survival! Elizabeth Tracey reports Read More »
American Cancer Society data find that the majority of people who are diagnosed with cancers of all types will still be alive five years later. Johns Hopkins Kimmel Cancer Center director William Nelson says this is good news indeed. Nelson: … There’s good news regarding survival when cancer if found, Elizabeth Tracey reports Read More »
PICS stands for post intensive care syndrome, and it is characterized by a number of physical and mental health conditions that may follow someone’s stay in an ICU. Rohan Mathur, a critical care expert at Johns Hopkins, says fatigue, memory … Who is at risk to develop PICS? Elizabeth Tracey reports Read More »
Physical and mental health issues can follow a stay in an intensive care unit, a condition known as PICS, for post intensive care syndrome. Rohan Mathur, a critical care expert at Johns Hopkins, says now that more attention is being … What can be done about PICS? Elizabeth Tracey reports Read More »
When someone has survived an intensive care unit stay, they may experience a host of challenges to their wellbeing known collectively as post intensive care syndrome, or PICS. Critical care expert Rohan Mathur at Johns Hopkins says sometimes the worst … How can you tell if PICS is present? Elizabeth Tracey reports Read More »
PICS stands for post intensive care syndrome, and recent data indicate that perhaps the majority of people who’ve been hospitalized in an ICU will have what are called sequelae, or lingering issues once they’re stepped down or discharged. Johns Hopkins … What kinds of issues may remain after someone has been in an intensive care unit? Elizabeth Tracey reports Read More »
Once you’ve made it through a stay in an intensive care unit, you can simply move forward in your life, right? Not exactly, as recent research indicates. So-called post intensive care syndrome, or PICS, can continue to impact the life … What is post-intensive care syndrome? Elizabeth Tracey reports Read More »
Maybe you’ve heard of CAR-T cells, a type of cell you have in your body that is supercharged in a lab and put back in to fight things like cancer. Biomedical engineering expert Jordan Green at Johns Hopkins and colleagues … There’s a new technique that may revolutionize one type of T cell therapy, Elizabeth Tracey reports Read More »
CAR-T cells are a type of immune cell that have proven very effective for treating some types of cancer, yet limitations to their use exist. Biomedical engineering expert Jordan Green at Johns Hopkins says limitations including lengthy time and expense … Can an injectable particle help supercharge your T cells? Elizabeth Tracey reports Read More »
Using polyester to wrap mRNA to create an injectable particle may soon enable targeting of your T cells to fight some cancers and autoimmune diseases. That’s according to research by Jordan Green, a biomedical engineering expert at Johns Hopkins, and colleagues. … Can an mRNA containing particle help direct your T cells to specific targets? Elizabeth Tracey reports Read More »
Let’s say I take one type of immune cell from your blood, grow it in a lab and use a virus to cause changes in that cell so it recognizes cancer. Then I put it back in your body to … Temporary changes to T cells may empower new treatments for cancer and autoimmune disease, Elizabeth Tracey reports Read More »
Comments
Download from Google Play
Download from App Store
United States